JRCT ID: jRCT2080223725
Registered date:21/11/2017
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Pruritus |
Date of first enrollment | 21/11/2017 |
Target sample size | 240 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : JTS-661 INN of investigational material : Serlopitant Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 74age old |
Gender | Both |
Include criteria | - Inadequate response to current therapies - Numerical rating scale score of 6 or more |
Exclude criteria |
Related Information
Primary Sponsor | JAPAN TABACCO INC. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-173781 |
Contact
Public contact | |
Name | |
Address | clinicaltrials-info-j@jt.com |
Telephone | |
Affiliation | Japan Tobacco Inc. |
Scientific contact | |
Name | |
Address | clinicaltrials-info-j@jt.com |
Telephone | |
Affiliation | Japan Tobacco Inc. |